Evidence map›Paper›PMID 40162751›Full record

ArticleMicrobiology spectrum2025

Gut microbiota's role in the enhancement of type 2 diabetes treatment by a traditional Chinese herbal formula compared to metformin.

Chengdong Xia, Liya Yue, Yinyu Wang, Cuidan Li, Guannan Ma, Yingjiao Ju, Peihan Wang, Jie Wang, Xiaoyuan Jiang, Xiaotong Wang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chengdong Xia *Department of Endocrinology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Liya Yue *China National Center for Bioinformation, Beijing, China.
Yinyu Wang *China National Center for Bioinformation, Beijing, China.
Cuidan Li *China National Center for Bioinformation, Beijing, China.
Guannan Ma *China National Center for Bioinformation, Beijing, China.
Yingjiao JuChina National Center for Bioinformation, Beijing, China.
Peihan WangChina National Center for Bioinformation, Beijing, China.
Jie WangChina National Center for Bioinformation, Beijing, China.
Xiaoyuan JiangChina National Center for Bioinformation, Beijing, China.
Xiaotong WangChina National Center for Bioinformation, Beijing, China.ORCID 0000-0002-9867-418X
Fei ChenChina National Center for Bioinformation, Beijing, China.ORCID 0000-0003-3895-6318

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM) is a rapidly increasing metabolic disorder that poses a significant threat to global public health. Recent evidence suggests that targeting the gut microbiota through dietary and pharmaceutical interventions can effectively manage T2DM. In this study, we developed a novel Chinese herbal formula, CCM, specifically for T2DM, composed of

Indexed as

Diabetes Mellitus, Type 2Drugs, Chinese HerbalGastrointestinal MicrobiomeHypoglycemic AgentsMetforminAnimalsBacteriaBlood GlucoseDisease Models, AnimalMaleMiceMice, Inbred C57BLBlood GlucoseDrugs, Chinese HerbalHypoglycemic AgentsMetformingut microbiotametformintraditional Chinese medicinetype 2 diabetes mellitus

Identifiers

PMID40162751
PMCPMC12054121

What Socratic holds

Texttitle and abstract
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.